Skip to main content
. 2016 Oct 3;26(1):36–42. doi: 10.1055/s-0036-1593445

Table 2. Comparison of clinical characteristics in ankylosing spondylitis and healthy controls.

Variables Ankylosing spondylitis Healthy controls p Value
n 30 25
EPC % 0.020 ± 0.001 0.040 ± 0.010 < 0.001
FMD % 7.35 ± 2.54 10.27 ± 1.73 0.002
CIMT (cm) 0.63 ± 0.01 0.35 ± 0.02 < 0.001
TNF-α (pg/mL) 5.07 ± 2.04 3.6 ± 1.5 0.001
IL-6 (pg/mL) 8.77 ± 3.67 4.2 ± 2.83 0.004
IL-1 (pg/mL) 179.0 ± 74.8 102.4 ± 36.3 0.001

Abbreviations: CIMT, carotid intima-media thickness; EPC, endothelial progenitor cells; FMD, flow-mediated dilatation; IL-1, interleukin-1; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α.

Note: Values are mean ± SD. Values in bold indicate, p-value < 0.05.